OTC Markets OTCPK - Delayed Quote USD
Enzolytics, Inc. (ENZC)
0.0007
0.0000
(0.00%)
At close: April 23 at 3:01:12 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Harry H. Zhabilov Jr., BSc, McS Science | CSO & Chairman | -- | -- | 1967 |
| Steven Sharabura | Chief Executive Officer | -- | -- | -- |
| Mr. Charles S. Cotropia | President & Director | -- | -- | -- |
| Diana Zhabilov | Chief Financial Officer | -- | -- | -- |
Enzolytics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
Corporate Governance
Enzolytics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
HALB Halberd Corporation
0.0017
-5.56%
ENDV Endonovo Therapeutics, Inc.
0.0003
0.00%
TXTM ProText Mobility, Inc.
0.0007
-12.50%
APRE Aprea Therapeutics, Inc.
1.5000
-2.60%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
RNAZ TransCode Therapeutics, Inc.
0.3140
+1.00%
BRTX BioRestorative Therapies, Inc.
1.7300
+0.58%
UNCY Unicycive Therapeutics, Inc.
0.6342
+1.75%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%
OGEN Oragenics, Inc.
0.1940
+3.74%